{
    "1687448300591476737": {
        "author_id": "5383942",
        "created_at": "2023-08-04T13:00:00.000Z",
        "edit_history_tweet_ids": [
            "1687448300591476737"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 5,
                    "normalized_text": "GSK",
                    "probability": 0.7502,
                    "start": 3,
                    "type": "Organization"
                },
                {
                    "end": 85,
                    "normalized_text": "malaria",
                    "probability": 0.512,
                    "start": 79,
                    "type": "Other"
                }
            ],
            "hashtags": [
                {
                    "end": 86,
                    "start": 78,
                    "tag": "malaria"
                }
            ],
            "urls": [
                {
                    "display_url": "gsk.to/3QrrEaa",
                    "end": 169,
                    "expanded_url": "https://gsk.to/3QrrEaa",
                    "start": 146,
                    "status": 200,
                    "unwound_url": "https://www.gsk.com/en-gb/behind-the-science-magazine/malaria-vaccine-children-mosquitos-single-dose-treatment/?linkId=100000212336588",
                    "url": "https://t.co/JaA8emCniF"
                }
            ]
        },
        "id": "1687448300591476737",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 0,
            "impression_count": 3392,
            "like_count": 14,
            "quote_count": 0,
            "reply_count": 1,
            "retweet_count": 5
        },
        "text": "At GSK, we\u2019ve been uniting our science, technology and talent to get ahead of #malaria for over 70 years, and we\u2019re not stopping. Find out more \ud83d\udc47 https://t.co/JaA8emCniF"
    }
}